(INDI) indie Semiconductor - Overview
Stock: Semiconductors, Sensors, Cameras, LiDAR, Photonics
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 76.8% |
| Relative Tail Risk | -13.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.17 |
| Alpha | -42.24 |
| Character TTM | |
|---|---|
| Beta | 2.545 |
| Beta Downside | 2.536 |
| Drawdowns 3y | |
|---|---|
| Max DD | 85.45% |
| CAGR/Max DD | -0.26 |
Description: INDI indie Semiconductor January 26, 2026
Indie Semiconductor (NASDAQ: INDI) designs, manufactures, and integrates automotive-grade semiconductors and software for advanced driver-assistance systems (ADAS), driver automation, in-cabin monitoring, connected-car functions, and vehicle electrification. Its product portfolio includes ultrasonic and radar sensors, front- and side-facing cameras, LiDAR units, long-range radar, and photonic components such as fiber-Bragg gratings and low-noise lasers, sold across North America, Greater China, Europe, South Korea, and the broader Asia-Pacific region.
According to the company’s latest Form 10-K (filed Feb 2026), INDI reported FY 2025 revenue of $212 million, up 18 % YoY, driven primarily by a 24 % increase in ADAS sensor shipments. Gross margin improved to 38 % from 34 % a year earlier, reflecting higher mix of high-margin photonic modules. Cash and short-term investments stood at $95 million, giving the firm ~1.5 years of runway at current burn rates. These figures are subject to revision pending the upcoming Q1 2026 earnings release.
The automotive semiconductor market is expanding at a compound annual growth rate of roughly 12 % through 2028 (S&P Global, 2024), fueled by accelerating EV adoption, stricter safety regulations mandating Level-2/3 autonomy, and rising demand for over-the-air updates that require robust in-vehicle computing. INDI’s focus on sensor-fusion hardware positions it to capture a share of the projected $85 billion ADAS spend by 2027, though competition from larger incumbents (e.g., NXP, Infineon) and supply-chain constraints remain material risks.
For a deeper, data-driven assessment of INDI’s valuation relative to its peers, you might explore the analytics platform ValueRay.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -144.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA 3.22 > 1.0 |
| NWC/Revenue: 100.2% < 20% (prev 61.16%; Δ 39.09% < -1%) |
| CFO/TA -0.06 > 3% & CFO -49.5m > Net Income -144.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (199.3m) vs 12m ago 11.05% < -2% |
| Gross Margin: 23.78% > 18% (prev 0.28%; Δ 2350 % > 0.5%) |
| Asset Turnover: 26.31% > 50% (prev 28.69%; Δ -2.38% > 0%) |
| Interest Coverage Ratio: -8.51 > 6 (EBITDA TTM -96.4m / Interest Expense TTM 16.2m) |
Altman Z'' -3.16
| A: 0.25 (Total Current Assets 297.1m - Total Current Liabilities 79.2m) / Total Assets 855.1m |
| B: -0.71 (Retained Earnings -605.9m / Total Assets 855.1m) |
| C: -0.17 (EBIT TTM -138.1m / Avg Total Assets 826.3m) |
| D: -1.33 (Book Value of Equity -616.2m / Total Liabilities 462.2m) |
| Altman-Z'' Score: -3.16 = D |
Beneish M -3.07
| DSRI: 1.00 (Receivables 53.2m/56.2m, Revenue 217.4m/228.8m) |
| GMI: 1.17 (GM 23.78% / 27.86%) |
| AQI: 0.92 (AQ_t 0.59 / AQ_t-1 0.63) |
| SGI: 0.95 (Revenue 217.4m / 228.8m) |
| TATA: -0.11 (NI -144.5m - CFO -49.5m) / TA 855.1m) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of INDI shares?
Over the past week, the price has changed by -15.15%, over one month by -0.55%, over three months by -24.17% and over the past year by -15.74%.
Is INDI a buy, sell or hold?
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the INDI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.1 | 68.7% |
| Analysts Target Price | 6.1 | 68.7% |
| ValueRay Target Price | 3 | -17% |
INDI Fundamental Data Overview February 03, 2026
P/S = 3.8212
P/B = 2.3542
Revenue TTM = 217.4m USD
EBIT TTM = -138.1m USD
EBITDA TTM = -96.4m USD
Long Term Debt = 339.1m USD (from longTermDebt, last quarter)
Short Term Debt = 14.4m USD (from shortTermDebt, last quarter)
Debt = 367.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 196.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.03b USD (830.7m + Debt 367.2m - CCE 171.2m)
Interest Coverage Ratio = -8.51 (Ebit TTM -138.1m / Interest Expense TTM 16.2m)
EV/FCF = -15.89x (Enterprise Value 1.03b / FCF TTM -64.6m)
FCF Yield = -6.29% (FCF TTM -64.6m / Enterprise Value 1.03b)
FCF Margin = -29.73% (FCF TTM -64.6m / Revenue TTM 217.4m)
Net Margin = -66.45% (Net Income TTM -144.5m / Revenue TTM 217.4m)
Gross Margin = 23.78% ((Revenue TTM 217.4m - Cost of Revenue TTM 165.7m) / Revenue TTM)
Gross Margin QoQ = -30.71% (prev 40.56%)
Tobins Q-Ratio = 1.20 (Enterprise Value 1.03b / Total Assets 855.1m)
Interest Expense / Debt = 1.18% (Interest Expense 4.35m / Debt 367.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -109.1m (EBIT -138.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.75 (Total Current Assets 297.1m / Total Current Liabilities 79.2m)
Debt / Equity = 0.99 (Debt 367.2m / totalStockholderEquity, last quarter 369.2m)
Debt / EBITDA = -2.03 (negative EBITDA) (Net Debt 196.1m / EBITDA -96.4m)
Debt / FCF = -3.03 (negative FCF - burning cash) (Net Debt 196.1m / FCF TTM -64.6m)
Total Stockholder Equity = 395.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -17.48% (Net Income -144.5m / Total Assets 855.1m)
RoE = -36.50% (Net Income TTM -144.5m / Total Stockholder Equity 395.8m)
RoCE = -18.79% (EBIT -138.1m / Capital Employed (Equity 395.8m + L.T.Debt 339.1m))
RoIC = -14.31% (negative operating profit) (NOPAT -109.1m / Invested Capital 762.4m)
WACC = 10.89% (E(830.7m)/V(1.20b) * Re(15.29%) + D(367.2m)/V(1.20b) * Rd(1.18%) * (1-Tc(0.21)))
Discount Rate = 15.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.62%
Fair Price DCF = unknown (Cash Flow -64.6m)
EPS Correlation: -8.53 | EPS CAGR: -47.89% | SUE: -4.0 | # QB: 0
Revenue Correlation: 81.41 | Revenue CAGR: 31.98% | SUE: -0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=+0.000 | Revisions Net=-4 | Analysts=7
EPS next Year (2026-12-31): EPS=-0.05 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+83.3% | Growth Revenue=+30.1%